Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ClearPoint Neuro Inc (CLPT) vs Dicks Sporting Goods Inc (DKS) Price & Performance

ClearPoint Neuro IncTrade
Dicks Sporting Goods IncTrade

Price performance (Past 24H)

Key statistics

ClearPoint Neuro Inc vs Dicks Sporting Goods Inc — how do they compare? ClearPoint Neuro Inc trades at $14.64 (market cap $454.21M), while Dicks Sporting Goods Inc trades at $202.11 (market cap $18.35B). The key difference: Dicks Sporting Goods Inc is far larger — about 40.4× ClearPoint Neuro Inc's market cap, and Dicks Sporting Goods Inc pays a 2.44% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.

CLPTDKS
Market Cap
$454.21M$18.35B
Sector
HealthConsumer Cyclical
52-Week High
$29.60$239.17
52-Week Low
$8.66$187.78
Enterprise Value
$488.79M$25.14B
Dividend Yield
2.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ClearPoint Neuro Inc

ClearPoint Neuro (CLPT) trades at $14.56, down slightly by 0.07% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q2 2026 revenue growth to $42 million but missed earnings estimates with a loss of $0.38 per share, reflecting ongoing investment in clinical and preclinical services. Despite negative net income margins and cash flow challenges, analyst consensus remains unanimously bullish with 3 buy ratings.

The outlook hinges on successful execution of growth initiatives in neuro drug delivery and regulatory progress with partners, though high valuation multiples and persistent losses pose significant risks. Near-term catalysts include Q3 2026 earnings and partner developments, but investors face volatility from operational cash burn and competitive pressures.

Dicks Sporting Goods Inc

Dick's Sporting Goods (DKS) trades at $201.95, down 5.67% in the past 24 hours, with technical indicators showing a bearish trend and key support at $198. Fundamentally, the company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $2.90 beating expectations, and maintains solid profitability with a 32.21% gross margin and 20.9% ROE. Recent news highlights analyst upgrades and positive coverage, while the company announced a $1.25 dividend payable in June 2026.

The outlook for DKS is mixed; analyst consensus is bullish with a $263.22 price target and no sell ratings, but technical weakness and a recent decline pose near-term risks. Investment opportunities include undervaluation based on a P/E of 19.96 and accelerating sales growth, while risks involve competitive pressures and potential fiduciary concerns highlighted in recent shareholder litigation news.

Returns comparison

Trailing returns across standard periods

About ClearPoint Neuro Inc

ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.

Read more on CLPT

About Dicks Sporting Goods Inc

Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.

Read more on DKS